West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.

doi:10.4269/ajtmh.16-0053

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.

The American journal of tropical medicine and hygiene - 2 Nov 2016

Dieye Baba, Affara Muna, Sangare Lassana, Joof Fatou, Ndiaye Yaye D, Gomis Jules F, Ndiaye Mouhamadou, Mbaye Aminata, Diakite Mouhamadou, Sy Ngayo, Mbengue Babacar, Deme Awa B, Daniels Rachel, Ahouidi Ambroise D, Dieye Tandakha, Abdullahi Ahmad, Doumbia Seydou, Ndiaye Jean L, Diarra Ayouba, Ismaela Abubakar, Coulibaly Mamadou, Welty Clint, Ngwa Alfred Amambua, Shaffer Jeffrey, D'Alessandro Umberto, Volkman Sarah K, Wirth Dyann F, Krogstad Donald J, Koita Ousmane, Nwakanma Davis, Ndiaye Daouda

Abstract excerpt

In 2006, artemether-lumefantrine (AL) became the first-line treatment of uncomplicated malaria in Senegal, Mali, and the Gambia. To monitor its efficacy, between August 2011 and November 2014, children with uncomplicated Plasmodium falciparum malaria were treated with AL and followed up for 42 days. A total of 463 subjects were enrolled in three sites (246 in Senegal, 97 in Mali, and 120 in Gambia). No early...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Artemisinins

Share to Ethanolamines

Share to Fluorenes

Share to Gambia

Share to Mali

Share to Multidrug Resistance-Associated Proteins

Share to Senegal

Source

Open in PubMed Open full text

Identifiers

PMID: 27549635
DOI: 10.4269/ajtmh.16-0053
PMCID: PMC5094217

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia.PMID 27549635Read ↗

Therapeutic efficacy of artemether–lumefantrine in North-Eastern states of India and prevalence of drug resistance-associated molecular markersSemantic proximity Read ↗

Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.Semantic proximity Read ↗

Assessing the Therapeutic Efficacy of Artemether-Lumefantrine for Uncomplicated Malaria in Lagos, Nigeria: A Comprehensive Study on Treatment Response and Resistance MarkersSemantic proximity Read ↗

Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015–2016Semantic proximity Read ↗

Clinical efficacy of artemisinin-lumefantrine and status of antifolate drug resistance markers in western KenyaSemantic proximity Read ↗

What are the effects of drug resistance on the global spread of malaria? A systematic literature reviewSemantic proximity Read ↗

Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trialSemantic proximity Read ↗

[Monitoring the Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria by Kelch 13 Gene Mutations in Bangui, Central African Republic].Semantic proximity Read ↗

Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.Semantic proximity Read ↗

Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers.Semantic proximity Read ↗

Clinical evidence of Kelch13-dependent and -independent malaria treatment failure with Artemether-LumefantrineSemantic proximity Read ↗

Country-Wide Surveillance of Molecular Markers of Antimalarial Drug Resistance in Senegal by Use of Positive Malaria Rapid Diagnostic Tests.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.